Annual Retained Earnings
-$1.12 B
-$287.22 M-34.37%
December 31, 2024
Summary
- As of March 13, 2025, AXSM annual retained earnings is -$1.12 billion, with the most recent change of -$287.22 million (-34.37%) on December 31, 2024.
- During the last 3 years, AXSM annual retained earnings has fallen by -$713.59 million (-174.39%).
- AXSM annual retained earnings is now -50278.56% below its all-time high of -$2.23 million, reached on December 31, 2013.
Performance
AXSM Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.12 B
-$74.91 M-7.15%
December 31, 2024
Summary
- As of March 13, 2025, AXSM quarterly retained earnings is -$1.12 billion, with the most recent change of -$74.91 million (-7.15%) on December 31, 2024.
- Over the past year, AXSM quarterly retained earnings has dropped by -$287.22 million (-34.37%).
- AXSM quarterly retained earnings is now -13543.94% below its all-time high of -$8.23 million, reached on December 31, 2014.
Performance
AXSM Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AXSM Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -34.4% | -34.4% |
3 y3 years | -174.4% | -34.4% |
5 y5 years | -538.3% | -538.3% |
AXSM Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -174.4% | at low | -174.4% | at low |
5 y | 5-year | -538.3% | at low | -538.3% | at low |
alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Axsome Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -$1.12 B(+34.4%) | -$1.12 B(+7.1%) |
Sep 2024 | - | -$1.05 B(+6.6%) |
Jun 2024 | - | -$983.27 M(+8.8%) |
Mar 2024 | - | -$903.93 M(+8.2%) |
Dec 2023 | -$835.57 M(+40.1%) | -$835.57 M(+13.4%) |
Sep 2023 | - | -$736.92 M(+9.2%) |
Jun 2023 | - | -$674.72 M(+11.1%) |
Mar 2023 | - | -$607.55 M(+1.9%) |
Dec 2022 | -$596.33 M(+45.7%) | -$596.33 M(+11.4%) |
Sep 2022 | - | -$535.09 M(+9.1%) |
Jun 2022 | - | -$490.27 M(+9.2%) |
Mar 2022 | - | -$448.83 M(+9.7%) |
Dec 2021 | -$409.20 M(+46.8%) | -$409.20 M(+9.1%) |
Sep 2021 | - | -$375.22 M(+10.2%) |
Jun 2021 | - | -$340.34 M(+10.5%) |
Mar 2021 | - | -$308.06 M(+10.5%) |
Dec 2020 | -$278.80 M(+58.5%) | -$278.80 M(+11.7%) |
Sep 2020 | - | -$249.63 M(+10.1%) |
Jun 2020 | - | -$226.71 M(+8.8%) |
Mar 2020 | - | -$208.38 M(+18.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | -$175.90 M(+63.5%) | -$175.90 M(+16.4%) |
Sep 2019 | - | -$151.09 M(+14.5%) |
Jun 2019 | - | -$131.95 M(+11.6%) |
Mar 2019 | - | -$118.19 M(+9.9%) |
Dec 2018 | -$107.55 M(+40.4%) | -$107.55 M(+9.8%) |
Sep 2018 | - | -$97.95 M(+9.2%) |
Jun 2018 | - | -$89.67 M(+10.2%) |
Mar 2018 | - | -$81.39 M(+6.3%) |
Dec 2017 | -$76.58 M(+60.8%) | -$76.58 M(+10.7%) |
Sep 2017 | - | -$69.15 M(+10.3%) |
Jun 2017 | - | -$62.72 M(+12.7%) |
Mar 2017 | - | -$55.64 M(+16.8%) |
Dec 2016 | -$47.64 M(+133.1%) | -$47.64 M(+18.2%) |
Sep 2016 | - | -$40.31 M(+21.7%) |
Jun 2016 | - | -$33.12 M(+34.3%) |
Mar 2016 | - | -$24.65 M(+20.6%) |
Dec 2015 | -$20.44 M(+148.4%) | -$20.44 M(+32.8%) |
Sep 2015 | - | -$15.39 M(+23.1%) |
Jun 2015 | - | -$12.50 M(+51.9%) |
Dec 2014 | -$8.23 M(+269.2%) | -$8.23 M |
Dec 2013 | -$2.23 M | - |
FAQ
- What is Axsome Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Axsome Therapeutics?
- What is Axsome Therapeutics annual retained earnings year-on-year change?
- What is Axsome Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly retained earnings year-on-year change?
What is Axsome Therapeutics annual retained earnings?
The current annual retained earnings of AXSM is -$1.12 B
What is the all time high annual retained earnings for Axsome Therapeutics?
Axsome Therapeutics all-time high annual retained earnings is -$2.23 M
What is Axsome Therapeutics annual retained earnings year-on-year change?
Over the past year, AXSM annual retained earnings has changed by -$287.22 M (-34.37%)
What is Axsome Therapeutics quarterly retained earnings?
The current quarterly retained earnings of AXSM is -$1.12 B
What is the all time high quarterly retained earnings for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly retained earnings is -$8.23 M
What is Axsome Therapeutics quarterly retained earnings year-on-year change?
Over the past year, AXSM quarterly retained earnings has changed by -$287.22 M (-34.37%)